Lake Street initiated coverage on PetMed Express with a new price target
$PETS
Retail-Drug Stores and Proprietary Stores
Consumer Staples
Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/25/2023 | $20.00 | Buy | Lake Street |
| 1/25/2022 | $25.00 → $21.00 | Underweight | Morgan Stanley |
| 1/20/2022 | $32.00 | Neutral → Buy | Sidoti |
| 11/18/2021 | $25.00 | Underweight | Morgan Stanley |
| 10/1/2021 | $28.00 | Hold | Jefferies |
| 8/5/2021 | $22.00 | Underperform | Credit Suisse |
DELRAY BEACH, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), will participate in the Sidoti Micro Cap Conference, to be held November 13-14, 2024 virtually. Sandra Campos, CEO and President, will meet with investors and present at approximately 1:45 p.m. Eastern Time on Wednesday, November 13, 2024. A live webcast of the presentation will be available on the "Events & Presentations" section of PetMed's investor relations website at https://investors.petmeds.com or directly here. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in the consumer pet healthcare sector. As a national online retailer wit
DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its second quarter ended September 30, 2024. Second Quarter Fiscal 2025 Financial Highlights Net sales of $59.6 million.Gross margin of 29.1%, an increase of 0.8% compared to the prior year period.Net income of $2.3 million, or $0.11 per diluted share, compared to net income of $0.7 million, or $0.03 per diluted share, in the prior year period. Adjusted EBITDA of $2.1 million improved sequentially from an Adjusted EBITDA loss of $(1.5) million in the first quarter of fiscal 2025 and compared to Adjusted EBITDA of $
DELRAY BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Wednesday, November 6, 2024 at 4:30pm Eastern Time to discuss its financial results for the fiscal second quarter ended September 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Wednesday, November 6, 2024Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
10-Q - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00
Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously
Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00
DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of retail and ecommerce veteran Robyn D'Elia as Chief Financial Officer ("CFO") effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning across multiple industries, including 24 years at Bed Bath & Beyond where she served in senior leadership roles across finance for two decades, and served as CFO from 2018 to 2020. Most recently D'Elia served as CFO at Odeko, a privately held all-in-one operations partner for independent coffee shops, cafes and ot
DELRAY BEACH, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Doug Krulik as Chief Accounting Officer (CAO) effective August 19, 2024. Krulik comes to PetMeds with more than 20 years of leadership experience in finance and accounting, most recently with Etherio Holdings as its Vice President Finance and Controller. In this newly created role, he will oversee all aspects of the Company's accounting functions, including financial reporting, treasury, tax, compliance, and internal controls. Krulik will report directly to the Office of the Chief Financial Officer. "Doug'
Caroline Conegliano appointed Chief Operating Officer Umesh Sripad appointed Chief Digital and Technology Officer Company Announces CFO transition DELRAY BEACH, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced several changes to its executive leadership team to further advance key initiatives to improve the customer experience, and to accelerate growth and profitability. Chief Operating Officer Caroline Conegliano joins PetMeds as Chief Operating Officer (COO), in a newly created role and expansion of the executive leadership team. Ms. Conegliano brings nearly two decades of experi
Investor Ryan Cohen founded Chewy Inc (NYSE:CHWY) back in 2011 as a play on the growing trend of pet supplies and pet health products. New data suggests Cohen may have been early to the trend, with spending on pet supplies and pet insurance seeing a large increase. What Happened: Serving as CEO of Chewy from 2011 to 2018, Cohen put an emphasis on the wide variety of pet products offered to consumers online and providing strong customer service. Cohen sold Chewy to PetSmart in 2017 for $3.35 billion in the largest e-commerce acquisition at the time. The investor may have been early to seeing trends in the pet sector, as a recent Similarweb report shows the pet supply category growing
Cat-themed cryptocurrencies surged Thursday after controversial trader "Roaring Kitty" returned to social media with an intriguing post. What Happened: Keith Gill, better known online as “Roaring Kitty,” posted a photo of a cartoonish dog, marking his first post since June 18. The photo shows a dog looking sideways, sticking its tongue out, without any captions. pic.twitter.com/jQBMX4jwjR— Roaring Kitty (@TheRoaringKitty) June 27, 2024 As has been the case over the last month-and-a-half, cryptocurrencies with "Kitty" in their names began to surge. Within minutes of the post, Solana (CRYPTO: SOL)-based Kitty AI spiked 34% to its weekly highs. While profit-taking halted the asc
Several pet-related stocks experienced significant upward movement on Thursday after Keith Gill, known as Roaring Kitty, posted a cartoon image of a dog on X, formerly known as Twitter. What’s Happening: Gill’s tweet featured a simple cartoon image of a dog, yet it was enough to send shares of several companies soaring. Among the notable movers were Chewy, Inc. (NYSE:CHWY), which saw its stock jump by around 10%, PetMed Express, Inc. (NASDAQ:PETS) around 4% and Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), also up 4%. What Else: Keith Gill, under the pseudonym Roaring Kitty, gained fame for his early and bullish stance on GameStop, which he shared on platforms like Reddit and
4 - PETMED EXPRESS INC (0001040130) (Issuer)
3 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its second quarter ended September 30, 2024. Second Quarter Fiscal 2025 Financial Highlights Net sales of $59.6 million.Gross margin of 29.1%, an increase of 0.8% compared to the prior year period.Net income of $2.3 million, or $0.11 per diluted share, compared to net income of $0.7 million, or $0.03 per diluted share, in the prior year period. Adjusted EBITDA of $2.1 million improved sequentially from an Adjusted EBITDA loss of $(1.5) million in the first quarter of fiscal 2025 and compared to Adjusted EBITDA of $
DELRAY BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Wednesday, November 6, 2024 at 4:30pm Eastern Time to discuss its financial results for the fiscal second quarter ended September 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Wednesday, November 6, 2024Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8
DELRAY BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its first quarter ended June 30, 2024. Quarterly Highlights for Q1, Fiscal 2025 Net sales were $68 million, (13)% lower than the prior year comparable quarter.Net income was $3.8 million, or $0.18 diluted earnings per share. This compares to net loss of $(1.1) million, or $(0.06) diluted earnings per share, for the prior year comparable quarter.Increase in net income is primarily attributed to a $8.7 million reversal of accumulated stock compensation expense associated with departure of the former CEO, partially off